These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28830286)

  • 1. Anticoagulation of Percutaneous Ventricular Assist Device Using Argatroban-Based Purge Solution: A Case Series.
    Blum EC; Martz CR; Selektor Y; Nemeh H; Smith ZR; To L
    J Pharm Pract; 2018 Oct; 31(5):514-518. PubMed ID: 28830286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an argatroban-based purge solution in a percutaneous ventricular assist device.
    Laliberte B; Reed BN
    Am J Health Syst Pharm; 2017 May; 74(9):e163-e169. PubMed ID: 28438820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective anticoagulation for a percutaneous ventricular assist device using a heparin-based purge solution.
    Jennings DL; Nemerovski CW; Kalus JS
    Ann Pharmacother; 2013 Oct; 47(10):1364-7. PubMed ID: 24259702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of a Dextrose-Only Purge Solution for an LVAD in Patients With Suspected HIT: A Case Series.
    Bowers RD; Nowak J; Bryan D; Biondi N; Dorsett B
    J Pharm Pract; 2021 Dec; 34(6):966-969. PubMed ID: 32588719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an argatroban systemic infusion and purge solution in a patient with a percutaneous ventricular assist device with suspected heparin-induced thrombocytopenia.
    Shtoyko AN; Feldman EA; Cwikla GM; Darko W; Green GR; Seabury RW
    Am J Health Syst Pharm; 2022 Jan; 79(1):e8-e13. PubMed ID: 34390237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation of Impella with a Bivalirudin Purge Solution.
    Szymanski TW; Weeks PA; Lee Y; Kumar S; Castillo B; Kar B; Gregoric ID
    ASAIO J; 2020; 66(9):e117-e120. PubMed ID: 32028295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation with temporary Impella device in patients with heparin-induced thrombocytopenia: A case series.
    Hohlfelder B; Militello MA; Tong MZ; Soltesz EG; Wanek MR
    Int J Artif Organs; 2021 May; 44(5):367-370. PubMed ID: 33050762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of a Percutaneously Inserted Ventricular Support Device Purge Solution Heparin 25 U/mL.
    Jiang C; Stuart M; Makowski C; Jennings DL; To L
    Ann Pharmacother; 2021 Feb; 55(2):174-180. PubMed ID: 32741200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Anticoagulation with Impella® Percutaneous Ventricular Assist Devices and Review of New Literature.
    Succar L; Sulaica EM; Donahue KR; Wanat MA
    J Thromb Thrombolysis; 2019 Aug; 48(2):284-291. PubMed ID: 30877619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Anticoagulation With an Ultra-Low Concentration Argatroban-Based Purge Solution for Percutaneous Ventricular Assist Device in Patient With Heparin-Induced Thrombocytopenia.
    Newsome AS; Taylor A; Garner S
    Hosp Pharm; 2021 Aug; 56(4):241-246. PubMed ID: 34381256
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation of a Percutaneous Left Ventricular Assist Device Using a Low-Dose Heparin Purge Solution Protocol: A Case Series.
    Newsome AS; Taylor A; Garner S
    J Pharm Pract; 2020 Aug; 33(4):471-476. PubMed ID: 30614366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Systemic Bivalirudin and an Anticoagulant-Free Purge Solution in a Percutaneous Left Ventricular Assist Device in a Patient With Heparin-Induced Thrombocytopenia.
    Kazmi H; Milkovits AE
    J Pharm Pract; 2021 Aug; 34(4):662-664. PubMed ID: 32508244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding Risks in Patients on Percutaneous Ventricular Assist Devices Receiving Two Different Dextrose Concentrations of Heparinized Purge Solution: A Case Series.
    Dietrich JN; Kazmi H
    J Pharm Pract; 2019 Aug; 32(4):464-469. PubMed ID: 29439593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation Management for Impella Percutaneous Ventricular Assist Devices: An Analysis of a Single-Center Experience.
    Wood E; Hayes C; Hart A
    Ann Pharmacother; 2020 Nov; 54(11):1073-1082. PubMed ID: 32410456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory Support.
    Allender JE; Reed BN; Foster JL; Moretz JD; Oliphant CS; Jennings DL; DiDomenico RJ; Coons JC
    Pharmacotherapy; 2017 Oct; 37(10):1272-1283. PubMed ID: 28741848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers.
    Reed BN; DiDomenico RJ; Allender JE; Coons JC; Cox JF; Johnson D; Oliphant CS; Jennings DL
    J Interv Cardiol; 2019; 2019():3791307. PubMed ID: 31772529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban as a substitute of heparin during cardiopulmonary bypass: a safe alternative?
    Follis F; Filippone G; Montalbano G; Floriano M; Lobianco E; D'Ancona G; Follis M
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):592-6. PubMed ID: 20061338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
    Meyer AL; Malehsa D; Kuehn C; Bara C; Gras C; Hafer C; Haverich A; Strüber M
    Ann Thorac Surg; 2009 Aug; 88(2):674-5. PubMed ID: 19632444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL; Hursting MJ; McCollum D
    Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.